State running out of drug to treat mucormycosis
The Hindu
Many families, hospitals finding it difficult to source them
The supply of the anti-fungal drugs Liposomal Amphotericin B or Amphotericin B, which are vital for treating mucormycosis, is drying up in Tamil Nadu with many patients’ families and hospitals finding it difficult to source them. Mucormycosis, a serious fungal infection now predominantly affecting people post-COVID-19 with uncontrolled diabetes, has been on the rise in several parts of the country. With cases gradually increasing in Tamil Nadu as well, the demand for the drug has shot up. An ENT specialist from a leading private hospital in Chennai said that Liposomal Amphotericin B or, in its absence, Amphotericin B was the first line of drug for mucormycosis and there were no effective alternatives. “Though Tamil Nadu is not yet seeing as many cases compared to other States, the drug shortage is already being felt,” he said.More Related News
Leaders and legislators hailing from Ballari, which is part of the Kalyana Karnataka region, seem to be a source of much political upheaval in Karnataka, going by recent history. This has been the case since the time illegal mining hit national and international headlines in the 2000s and the place gained reputation as “Republic of Ballari”.
The former BJP MLA of Udupi K. Raghupathi Bhat claimed on Saturday that he contesting the Legislative Council elections from South West Graduates’ Constituency as rebel candidate made the saffron party field its party leader C. T. Ravi in the biennial elections to the Legislative Council from the Legislative Assembly.